GlassScriptPhysician profile
David L Ekman
NPI 1821344490
$3,652.41
in general payments reported to CMS, 2019-2025
15 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $21.69 · 2021: $1,445 · 2022: $1,200 · 2023: $83.37 · 2024: $476 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,405.59 | 2021 | |
| Sioux Surgical INC | $1,335.02 | 2020-2025 | |
| Mimedx Group, INC. | $308.06 | 2024-2025 | |
| Integra Lifesciences Corporation | $185.80 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $176.68 | 2019-2024 | |
| Solventum Corporation | $60.62 | 2024-2025 | Prevena, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
| Averitas Pharma INC. | $57.84 | 2024-2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $24.50 | 2024 | Purified Cortrophin Gel |
| Stryker Corporation | $18.38 | 2025 | Augment Injectable, Anchorage, Easyfuse |
| Reprise Biomedical, INC. | $15.54 | 2025 | Miro3d |
| Merck Sharp & Dohme LLC | $14.58 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.44 | 2024 | Nuzyra |
| Abbott Laboratories | $12.92 | 2021 | |
| Lilly USA, LLC | $11.77 | 2021 | |
| Osiris Therapeutics INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ekman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.